Pediapharm (CVE:PDP) Stock Price Up 1.7% – Time to Buy?

Pediapharm Inc. (CVE:PDP)’s stock price shot up 1.7% on Thursday . The stock traded as high as C$0.31 and last traded at C$0.30. 26,000 shares were traded during trading, a decline of 74% from the average session volume of 100,369 shares. The stock had previously closed at C$0.30.

Pediapharm Price Performance

The company has a 50 day moving average price of C$0.30 and a 200-day moving average price of C$0.30. The company has a market cap of C$66.36 million and a price-to-earnings ratio of -4.11. The company has a quick ratio of 0.71, a current ratio of 1.12 and a debt-to-equity ratio of 186.87.

About Pediapharm

Pediapharm Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children. The company was incorporated in 2003 and is headquartered in Verdun, Canada.